Richard A Salzstein

Title: Richard A Salzstein: Innovator in Pharmaceutical and Medical Device Technologies

Introduction

Richard A Salzstein is a notable inventor based in Newark, DE (US). He has made significant contributions to the fields of pharmaceuticals and medical devices, holding a total of 2 patents. His work focuses on enhancing the effectiveness and reliability of drug delivery systems and medical implants.

Latest Patents

One of Salzstein's latest patents is for a highly compressible ethylcellulose for tableting. This pharmaceutical dosage form composition utilizes ethylcellulose with an ethoxyl range lower limit of 49.6% and a viscosity of less than 53 cps, combined with at least one active pharmaceutical ingredient. This innovative dosage form is designed to be highly compressible and compactable, resulting in harder tablets or pellets that offer improved release retardation compared to prior art tablets.

Another significant patent is for a composite femoral implant that boasts increased neck strength. This femoral implant for a hip prosthesis features a shaft oriented in a longitudinal direction, with a neck extending from the shaft at an acute angle. The implant is constructed from multiple layers of fibers in a matrix, where the fibers are predominantly unidirectional in each layer. The design ensures that at least 50% of the fibers are oriented in the acute angle direction, enhancing the implant's structural integrity.

Career Highlights

Richard A Salzstein is associated with Hercules Corporation, where he continues to innovate in his field. His work has contributed to advancements in both pharmaceutical formulations and orthopedic devices, showcasing his versatility as an inventor.

Collaborations

Salzstein has collaborated with notable colleagues such as Thomas Durig and Ronald Haywood Hall. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Richard A Salzstein exemplifies the spirit of innovation in the pharmaceutical and medical device industries. His patents reflect a commitment to improving patient outcomes through advanced technology.